The effect of local recurrence on survival in resected osteosarcoma
- PMID: 11165128
- DOI: 10.1016/s0959-8049(00)00362-2
The effect of local recurrence on survival in resected osteosarcoma
Abstract
The aim of this study was to assess the effect of local recurrence on survival in primary osteosarcoma. 559 patients entered into two randomised trials of the European Osteosarcoma Intergroup who received surgery for primary operable high-grade osteosarcoma of the extremities were included in this analysis. Proportional hazards modelling techniques were used to assess the relative importance of sex, age, site, surgery performed and local recurrence. The last of these was considered as a time-dependent covariate. 42/559 (8%) patients had a local recurrence. In the multivariate analysis, local recurrence was found to greatly increase the risk of death (hazard ratio (HR)=5.10, 95% confidence interval (CI) 3.51-7.41). Site and surgery performed also had a significant influence within this model. Using the technique of landmark analysis, with the landmark time set at 18 months, local recurrence alone had a significant influence on survival (HR=4.60, 95% CI 2.80-7.57). Local recurrence is an indicator of poorer survival for patients with operable primary osteosarcoma.
Similar articles
-
Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.Cancer. 2006 Oct 1;107(7):1607-16. doi: 10.1002/cncr.22197. Cancer. 2006. PMID: 16933325
-
Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.J Surg Oncol. 2012 Dec;106(7):820-5. doi: 10.1002/jso.23150. Epub 2012 Jun 27. J Surg Oncol. 2012. PMID: 22740310
-
Do pathological fractures influence survival and local recurrence rate in bony sarcomas?Eur J Cancer. 2007 Sep;43(13):1944-51. doi: 10.1016/j.ejca.2007.07.004. Epub 2007 Aug 14. Eur J Cancer. 2007. PMID: 17698347
-
Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.Eur J Cancer. 2011 Apr;47(6):895-902. doi: 10.1016/j.ejca.2010.11.036. Epub 2011 Jan 6. Eur J Cancer. 2011. PMID: 21216138
-
Dose-intensive versus dose-control chemotherapy for high-grade osteosarcoma: a meta-analysis.Eur Rev Med Pharmacol Sci. 2014;18(9):1383-90. Eur Rev Med Pharmacol Sci. 2014. PMID: 24867518 Review.
Cited by
-
RNA binding protein HuR promotes osteosarcoma cell progression via suppressing the miR-142-3p/HMGA1 axis.Oncol Lett. 2018 Aug;16(2):1475-1482. doi: 10.3892/ol.2018.8855. Epub 2018 May 31. Oncol Lett. 2018. PMID: 30008826 Free PMC article.
-
A popliteal giant synovial osteochondroma mimicking a parosteal osteosarcoma.World J Surg Oncol. 2013 Sep 25;11:241. doi: 10.1186/1477-7819-11-241. World J Surg Oncol. 2013. PMID: 24066980 Free PMC article.
-
RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis.Mol Ther Nucleic Acids. 2014 Sep 2;3(9):e189. doi: 10.1038/mtna.2014.35. Mol Ther Nucleic Acids. 2014. PMID: 25181275 Free PMC article.
-
What are the factors that affect survival and relapse after local recurrence of osteosarcoma?Clin Orthop Relat Res. 2014 Oct;472(10):3188-95. doi: 10.1007/s11999-014-3759-7. Epub 2014 Jul 1. Clin Orthop Relat Res. 2014. PMID: 24980644 Free PMC article.
-
Berberine inhibits the growth of osteosarcoma through modulating MMP/NM-23 and MAPK/JNK signal pathways.Am J Transl Res. 2023 Feb 15;15(2):729-744. eCollection 2023. Am J Transl Res. 2023. PMID: 36915782 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical